NTRK1 and acute myeloid leukemia: The genetic variations contribute to the occurrence and development of AML, mutations in the receptor tyrosine kinase FMS-Like Tyrosine Kinase-3 (FLT3) are present in about one-third of all the patients with AML [4, 5].